ZeroHarm Sciences, a startup in the health technology sector, has successfully raised ₹65 crore in funding. The primary investor in this funding round was Kotak Alternate Asset Managers Limited, specifically through its Kotak Life Sciences Fund I (KLSF-I), which contributed ₹40 crore to the investment.
This funding is expected to fuel ZeroHarm Sciences’ efforts in developing innovative solutions within the health tech space. The company aims to leverage this capital to advance its technology and expand its reach in the market, potentially leading to significant advancements in healthcare technology.
ZeroHarm Sciences’ ability to secure such a significant amount of funding underscores the growing interest and potential within the health tech sector. As technology continues to play a crucial role in revolutionizing healthcare, investments like these highlight the confidence that investors have in the future of tech-driven healthcare solutions.
Source: YourStory RSS Feed